TransPerfect Life Sciences Introduces Interactive CTMS Testing Solution


NEW YORK, November 11, 2021 / PRNewswire / – TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced the release of the Trial Management System clinical (CTMS) Trial Interactive (TI). This release is the industry’s only mobile CTMS, putting important actions and information within reach of research managers and CRAs and supporting a full author-to-archiving process.

Trial Interactive provides user-friendly document and trial management solutions to help pharmaceutical, biotechnology, medical device, and contract research (CRO) organizations efficiently streamline product development cycles. The platform improves the speed, quality and compliance of site identification, site feasibility, study start-up, site staff training, regulated content management, eISF and eTMF management. The addition of TI CTMS enables a single source of truth throughout the lifecycle, providing transparency to Trial Interactive solutions and any sponsor or CRO registration system. Fully connected solution, Trial Interactive offers quick to implement and cost effective solutions in a secure environment compliant with 21 CFR Part 11.

Designed by clinical professionals for clinical professionals, TI CTMS benefits include:

  • World class user experience – Time-saving and painless mobile-first interface with full-text and segmented metadata search, flexible filtering and exports, dark mode and one-click navigation, creates user experience the most user-friendly in the industry.
  • By Clinic, for Clinic – Enjoy greater efficiency without the hassle and get started quickly with no cumbersome configuration required and best practices built into the default configuration.
  • True SaaS solution – TI CTMS is a single-study or enterprise SaaS solution developed by experts. TransPerfect’s award-winning service teams support rapid implementation plans with full validation.
  • Ready for business – With the flexibility to align with large-scale operations, TI CTMS enables companies with complex study teams to easily update the system to meet unique requirements and gain access to an API full web services supporting third-party integrations.
  • Archive creation platform – Streamline processes and oversight with content management solutions supporting lifecycle document workflow, from site staff and study to eTMF in a seamless process.

As clinical operations become increasingly decentralized, TI CTMS continues Trial Interactive’s mission to deliver practical innovation to improve the efficiency of global clinical processes while reducing costs.

“After consulting with many organizations and colleagues over the years about CTMS, we recognized common challenges such as time-consuming setups, difficult navigation, and user experiences that are clearly developed without input from experts in clinical operations. . The end result is that the platforms don’t have the features that research managers and rating agencies really need, ”commented Michael smyth, Division President of TransPerfect Life Sciences. “TI CTMS was designed by clinical professionals for clinical professionals and reduced setup times while delivering powerful functionality in a clean user experience that perfectly meets the needs of sponsors and CROs.

President and CEO of TransPerfect Phil shawe said, “The launch of TI CTMS comes at a time when the conduct of remote and decentralized clinical trials is more important than ever. The CTMS is connected to our eTMF and other platform solutions to deliver a mobile experience that ensures study teams can work efficiently and at scale from any location. ”

To schedule a demo of Trial Interactive’s CTMS, contact us at [email protected].

About Trial Interactive
TransPerfect’s Interactive Trial is an industry leader in hands-on eClinic innovation that simplifies and automates clinical processes for sponsors, CROs and sites around the world. The unified 21 CFR Part 11 compliant platform enables an author to archive the experience of collaborating with solutions for clinical document management, site selection, site activation, e-learning , compliance training, quality, etc. Trial Interactive is systematically selected by healthcare professionals to offer the most complete and intuitive experience with the most comprehensive offer of TMF technologies and expert services. Trial Interactive helps study teams streamline their operations by reducing unnecessary expense, accelerating lead times, reducing compliance risks and improving operational excellence. For more information on Trial Interactive, please contact [email protected] or +1 212.400.8848, or visit

About TransPerfect Life Sciences
TransPerfect Life Sciences specializes in supporting the development and global commercialization of drugs, treatments and devices designed to improve and save lives. Our comprehensive solutions include eTMF and eClinical technologies, paper-based TMF migration, pharmacovigilance and security solutions, translation and language services, and call center support. With offices in over 100 cities around the world, TransPerfect is the perfect partner to ensure that your global launch has a global impact. For more information, please visit our website at

About TransPerfect
Transparency is the world’s largest supplier of Tongue and technological solutions for global affairs. From offices in more than 100 cities on six continents, TransPerfect offers a full range of services in more than 170 languages ​​to customers around the world. More than 5,000 organizations worldwide use TransPerfect GlobalLink® technology to simplify the management of multilingual content. With an unprecedented commitment to quality and customer service, TransPerfect is fully ISO 9001 and ISO 17100 approved. TransPerfect is headquartered in new York, with regional headquarters in London and Hong Kong. For more information, please visit our website at

SOURCE TransPerfect

Related links

Leave A Reply

Your email address will not be published.